Nyxoah (NYXH) Competitors $8.01 +0.08 (+0.95%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. LQDA, SSII, PLSE, INMD, MDXG, KMTS, SIBN, IRMD, CBLL, and EMBCShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nyxoah vs. Its Competitors Liquidia Technologies SS Innovations International Pulse Biosciences InMode MiMedx Group Kestra Medical Technologies SiBone iRadimed CeriBell Embecta Nyxoah (NASDAQ:NYXH) and Liquidia Technologies (NASDAQ:LQDA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment. Do analysts rate NYXH or LQDA? Nyxoah currently has a consensus target price of $14.50, suggesting a potential upside of 81.14%. Liquidia Technologies has a consensus target price of $26.89, suggesting a potential upside of 86.15%. Given Liquidia Technologies' higher probable upside, analysts plainly believe Liquidia Technologies is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Liquidia Technologies 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more volatility and risk, NYXH or LQDA? Nyxoah has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, Liquidia Technologies has a beta of -0.01, meaning that its share price is 101% less volatile than the S&P 500. Do insiders and institutionals hold more shares of NYXH or LQDA? 64.5% of Liquidia Technologies shares are held by institutional investors. 30.1% of Liquidia Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor NYXH or LQDA? In the previous week, Liquidia Technologies had 19 more articles in the media than Nyxoah. MarketBeat recorded 20 mentions for Liquidia Technologies and 1 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.89 beat Liquidia Technologies' score of 0.21 indicating that Nyxoah is being referred to more favorably in the media. Company Overall Sentiment Nyxoah Very Positive Liquidia Technologies Neutral Is NYXH or LQDA more profitable? Liquidia Technologies has a net margin of -903.80% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Liquidia Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,571.39% -63.37% -46.67% Liquidia Technologies -903.80%-177.91%-60.15% Which has stronger earnings and valuation, NYXH or LQDA? Nyxoah has higher earnings, but lower revenue than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.89M55.76-$64.10M-$2.13-3.76Liquidia Technologies$14.14M87.30-$130.39M-$1.58-9.14 SummaryLiquidia Technologies beats Nyxoah on 10 of the 16 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$272.65M$1.98B$5.56B$9.30BDividend YieldN/AN/A4.23%4.03%P/E Ratio-3.7634.1528.6119.64Price / Sales55.7614.98437.49188.30Price / CashN/A54.7436.0257.93Price / Book2.228.558.185.63Net Income-$64.10M-$62.39M$3.23B$257.73M7 Day Performance3.29%-2.01%-0.25%0.07%1 Month Performance3.29%10.04%5.40%8.32%1 Year Performance-14.84%3.57%26.35%13.78% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.8516 of 5 stars$8.01+0.9%$14.50+81.1%-14.7%$272.65M$4.89M-3.76110LQDALiquidia Technologies3.1968 of 5 stars$12.45+2.1%$26.89+116.0%+16.6%$1.04B$14M-7.8850Trending NewsInsider TradeSSIISS Innovations InternationalN/A$5.27-1.3%N/AN/A$1.03B$20.65M0.004PLSEPulse Biosciences3.715 of 5 stars$15.81+3.3%$22.00+39.2%-22.0%$1.03B$700K0.00140INMDInMode4.0614 of 5 stars$15.10-0.4%$18.54+22.8%-20.1%$958.25M$394.82M6.48480News CoveragePositive NewsMDXGMiMedx Group3.6738 of 5 stars$6.48+2.2%$12.50+92.9%-11.2%$936.43M$348.88M24.00870News CoverageAnalyst ForecastKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$804.64M$52.64M0.00300News CoverageSIBNSiBone3.9739 of 5 stars$18.01-2.5%$22.50+24.9%+8.6%$787.09M$167.18M-28.14350Positive NewsIRMDiRadimed4.7046 of 5 stars$59.02-4.5%$72.00+22.0%+25.8%$785.79M$73.24M38.08110CBLLCeriBell2.6065 of 5 stars$17.20-9.1%$32.14+86.9%N/A$684.19M$65.44M0.00N/AEMBCEmbecta4.7497 of 5 stars$10.03-2.8%$19.33+92.8%-25.4%$603.13M$1.08B11.142,100News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Liquidia Technologies Competitors SS Innovations International Competitors Pulse Biosciences Competitors InMode Competitors MiMedx Group Competitors Kestra Medical Technologies Competitors SiBone Competitors iRadimed Competitors CeriBell Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.